Skip to content

Aurinia Pharmaceuticals AUPH Lessee Operating Lease Liability Undiscounted Excess Amount

Lessee Operating Lease Liability Undiscounted Excess Amount at other companies

Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Abbott logo
AbbottABT

Other financials

Income statement

See full
Revenue$77.7M+24.4%
Gross profit$71.2M+32.1%
Operating income$41.4M+89.6%
Net income$34.4M+47.2%
EPS (diluted)$0.25+56.3%

Balance sheet

See full
Cash & equivalents$41.0M-38.3%
Total debt$85.2M-7.9%
Total equity$567.6M+62.1%
Total assets$724.0M+43.4%

Cash flow

See full
Operating cash flow$32.6M+2,405%

Valuation

See full
Market cap$2.39B+78.5%
Enterprise value$2.44B+78.3%
P/E-25.6×
P/S+2.6×

Profitability

See full
Gross margin89.7%+1.5pp
Operating margin41.7%+29.4pp
Net margin100%+83.9pp

Returns & leverage

See full
Return on equity65%+53.8pp
Debt / equity0.2×-0.1×
Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's lessee operating lease liability undiscounted excess amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aurinia Pharmaceuticals's lessee operating lease liability undiscounted excess amount?
Aurinia Pharmaceuticals (AUPH) reported lessee operating lease liability undiscounted excess amount of $362K in Q1 2026.
How has Aurinia Pharmaceuticals's lessee operating lease liability undiscounted excess amount changed year-over-year?
Aurinia Pharmaceuticals's lessee operating lease liability undiscounted excess amount decreased by 69.1% year-over-year, from $1.17M to $362K.